CMAX Stock Overview
CareMax, Inc. provides chronic disease management services through physicians and health care professionals.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
CareMax, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.73 |
| 52 Week High | US$4.89 |
| 52 Week Low | US$0.64 |
| Beta | 1.69 |
| 1 Month Change | -64.04% |
| 3 Month Change | -67.84% |
| 1 Year Change | -80.84% |
| 3 Year Change | -93.36% |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Recent updates
CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity
Jun 20
Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results
May 13Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%
Mar 11CareMax: Numbers Are Strong, Compelling Value On Offer
Sep 16CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M
Aug 09CareMax: Steward Health Care Acquisition Highlights Growth Ambitions
Jul 02CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries
Oct 18Shareholder Returns
| CMAX | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.6% | 1.5% | 0.1% |
| 1Y | -80.8% | -4.4% | 13.5% |
Return vs Industry: CMAX underperformed the US Healthcare industry which returned -4.4% over the past year.
Return vs Market: CMAX underperformed the US Market which returned 13.5% over the past year.
Price Volatility
| CMAX volatility | |
|---|---|
| CMAX Average Weekly Movement | 13.8% |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CMAX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: CMAX's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,500 | Carlos de Solo | https://www.caremax.com |
CareMax, Inc. provides chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States.
CareMax, Inc. Fundamentals Summary
| CMAX fundamental statistics | |
|---|---|
| Market Cap | US$84.07m |
| Earnings (TTM) | -US$207.15m |
| Revenue (TTM) | US$763.53m |
0.1x
P/S Ratio-0.4x
P/E RatioIs CMAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CMAX income statement (TTM) | |
|---|---|
| Revenue | US$763.53m |
| Cost of Revenue | US$672.25m |
| Gross Profit | US$91.28m |
| Other Expenses | US$298.42m |
| Earnings | -US$207.15m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.85 |
| Gross Margin | 11.95% |
| Net Profit Margin | -27.13% |
| Debt/Equity Ratio | 64.3% |
How did CMAX perform over the long term?
See historical performance and comparison